Table 7: Univariate and multivariate analysis of factors for vulnerability associated with 30-day all-cause mortality.

 

Univariate Analysis

Multivariate Analysis

Variable

30-Day All-Cause Mortality (%)

OR (95% CI) p-value

OR (95% CI) p-value

Male

6.1

2.20 (1.15-4.23) 0.015

2.50 (1.17-5.35) 0.019

Age ≥ 80 years

 7.3

2.78 (1.46-5.31) 0.001

1.71 (0.80-3.65) 0.167

Severe functional impairment

(Katz Index ≤ 2)

 11.0

3.66 (1.73-7.63) < 0.001

3.43 (1.27-9.21) 0.015

Frailty with dependence

(CFS ≥ 5)

 6.2

2.40 (1.24-4.63) 0.008

1.53 (0.65-3.60) 0.328

Presence of delirium/cognitive impairment

(4AT ≥ 4)

 9.3

3.09 (1.35-7.07) 0.005

1.40 (0.51-3.85) 0.516

Severe COVID-19 Pneumonia

(Stage 4 or 5)

12.7

5.61 (2.91-10.79) < 0.001

3.74 (1.77-7.92) < 0.001

COVID-19 Decision Support Tool

 4.6

2.06 (0.72-5.86) 0.169

-

Multiple Co-morbidities

(CCI ≥ 3)

 4.2

1.81 (0.24-13.48) 0.559

-

Polypharmacy

(≥ 5 medications)

14.4

1.23 (0.64-2.35) 0.534

-

OR: Odds Ratio; CI: Confidence Interval